Melatonin Glenmark (Melatonin)

Melatonin acts as an agonist at the MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus. By mimicking the natural hormone, it signals the body that it is nighttime, helping to synchronize the circadian rhythm and promote the onset of sleep.

The appropriate dose of Melatonin Glenmark is determined by the prescribing clinician based on the individual’s age, condition, and response. Dosage may vary, and patients should follow the specific instructions provided by their healthcare professional.

Safety data for melatonin use in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting therapy.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike many prescription hypnotics that act on GABA receptors, melatonin works by directly influencing the body’s circadian clock. This mechanism often results in fewer next‑day residual effects, making it a preferred option for short‑term sleep timing adjustments such as jet lag or shift work.

Melatonin Glenmark should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

The product is taken orally, typically with a glass of water. It is usually recommended to ingest the dose shortly before the desired bedtime, following the timing guidance given by the prescribing clinician.

Serious but rare risks include severe allergic reactions such as rash, itching, or anaphylaxis, as well as mood alterations like depression or agitation. Patients should seek immediate medical attention if they experience any signs of an allergic response or significant mood changes.

Individuals with known hypersensitivity to melatonin or any excipients in the formulation should avoid use. Additionally, patients taking certain medications that strongly interact with melatonin, such as specific anticoagulants or CYP1A2 inhibitors, should consult their healthcare provider before starting therapy.